[go: up one dir, main page]

AU2002366305A1 - 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression - Google Patents

2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression

Info

Publication number
AU2002366305A1
AU2002366305A1 AU2002366305A AU2002366305A AU2002366305A1 AU 2002366305 A1 AU2002366305 A1 AU 2002366305A1 AU 2002366305 A AU2002366305 A AU 2002366305A AU 2002366305 A AU2002366305 A AU 2002366305A AU 2002366305 A1 AU2002366305 A1 AU 2002366305A1
Authority
AU
Australia
Prior art keywords
quinolin
dihydro
inhibitors
induction
protein expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366305A
Inventor
Kyosuke Haze
Yutaka Kato
Shuji Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HSP Research Institute Inc
Mochida Pharmaceutical Co Ltd
Original Assignee
HSP Research Institute Inc
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HSP Research Institute Inc, Mochida Pharmaceutical Co Ltd filed Critical HSP Research Institute Inc
Publication of AU2002366305A1 publication Critical patent/AU2002366305A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002366305A 2001-12-14 2002-12-13 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression Abandoned AU2002366305A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-381656 2001-12-14
JP2001381656A JP2005139066A (en) 2001-12-14 2001-12-14 2,3-dihydro-1H-quinolin-4-one oxime derivative and heat shock protein expression induction inhibitor
PCT/JP2002/013076 WO2003051844A1 (en) 2001-12-14 2002-12-13 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression

Publications (1)

Publication Number Publication Date
AU2002366305A1 true AU2002366305A1 (en) 2003-06-30

Family

ID=19187364

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366305A Abandoned AU2002366305A1 (en) 2001-12-14 2002-12-13 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression

Country Status (3)

Country Link
JP (1) JP2005139066A (en)
AU (1) AU2002366305A1 (en)
WO (1) WO2003051844A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008024961A1 (en) * 2006-08-24 2008-02-28 Serenex, Inc. Dihydropyridazine, tetrahydropyridine, chromanone, and dihydronaphthalenone derivatives as heat-shock protein 90 inhibitors
US20110053873A1 (en) * 2008-02-01 2011-03-03 Takeda Pharmaceutical Company Limited Hsp90 inhibitors
CN104086361A (en) * 2014-07-25 2014-10-08 南通市华峰化工有限责任公司 Preparation method of 2-chloro-5-iodobenzoic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55122719A (en) * 1979-03-13 1980-09-20 Mochida Pharmaceut Co Ltd Medicine composition having antipyretic, analgesic, and anti-inflammatory action

Also Published As

Publication number Publication date
JP2005139066A (en) 2005-06-02
WO2003051844A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
MXPA03006010A (en) Substituted arylamine derivatives and methods of use.
GB0130789D0 (en) Application of spores
MXPA03006260A (en) Substituted amine derivatives and methods of use.
GB2373565B (en) Detonation transfer subassembly and method for use of the same
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2002340010A1 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
AU2002324598A1 (en) Trps as modifiers of the p53 pathway and methods of use
AU2002360733A1 (en) SUBSTITUTED 4,9-DIHYDROCYCLOPENTA(imn)PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
AU2002242085A1 (en) Methods and compositions useful for stimulating an immune response
AU2002336288A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
EP1411965A4 (en) Methods and compositions for controlling protein assembly or aggregation
EP1261623A4 (en) New retinol derivatives, the method of preparations and the uses thereof
ZA200204635B (en) Fragments and antagonists of heat shock protein 60.
EP1392317A4 (en) Substituted 1-benzazepines and derivatives thereof
WO2005115431A3 (en) Methods for inhibiting proteasome and heat shock protein 90
EP1421061A4 (en) Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
AU2001248277A1 (en) Shock heat treatment of polypeptides
AU2002366305A1 (en) 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression
AU2001251526A1 (en) Method of inactivating pathogens
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
GB0115126D0 (en) High temperature damper
AU2002325305A1 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
GB0100151D0 (en) Methods of sputtering
AU2001285814A1 (en) Use of the heat shock protein gp96

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase